Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156 USD | -1.90% | -5.01% | +25.55% |
Financials (USD)
Sales 2024 * | 260M | Sales 2025 * | 423M | Capitalization | 4.54B |
---|---|---|---|---|---|
Net income 2024 * | 46M | Net income 2025 * | 124M | EV / Sales 2024 * | 15.3 x |
Net cash position 2024 * | 564M | Net cash position 2025 * | 739M | EV / Sales 2025 * | 8.97 x |
P/E ratio 2024 * |
81.8
x | P/E ratio 2025 * |
31.1
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Krystal Biotech, Inc.
1 day | -1.85% | ||
1 week | -6.24% | ||
Current month | -10.61% | ||
1 month | -4.93% | ||
3 months | +24.06% | ||
6 months | +35.88% | ||
Current year | +28.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 16-04-14 | |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 16-10-31 |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Dino Rossi
BRD | Director/Board Member | 69 | 17-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 155.8 | -2.07% | 25 346 |
24-04-24 | 159 | -1.85% | 237,974 |
24-04-23 | 162 | +3.05% | 223,172 |
24-04-22 | 157.2 | -0.81% | 341,813 |
24-04-19 | 158.5 | -3.32% | 341,399 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.20% | 4.54B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+0.84% | 22.2B | |
-16.53% | 21.23B | |
-8.72% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- KRYS Stock